IL71017A - Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha - Google Patents

Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha

Info

Publication number
IL71017A
IL71017A IL71017A IL7101784A IL71017A IL 71017 A IL71017 A IL 71017A IL 71017 A IL71017 A IL 71017A IL 7101784 A IL7101784 A IL 7101784A IL 71017 A IL71017 A IL 71017A
Authority
IL
Israel
Prior art keywords
diagnosis
purification
detection
cell lines
monoclonal antibodies
Prior art date
Application number
IL71017A
Other versions
IL71017A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL71017A0 publication Critical patent/IL71017A0/en
Publication of IL71017A publication Critical patent/IL71017A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL71017A 1983-02-22 1984-02-21 Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha IL71017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306060 DE3306060A1 (en) 1983-02-22 1983-02-22 NEW IMMUNGLOBULIN-PRODUCING HYBRID CELL LINES, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
IL71017A0 IL71017A0 (en) 1984-05-31
IL71017A true IL71017A (en) 1987-12-31

Family

ID=6191474

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71017A IL71017A (en) 1983-02-22 1984-02-21 Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha

Country Status (7)

Country Link
EP (1) EP0119476A3 (en)
JP (1) JPS59224687A (en)
DE (1) DE3306060A1 (en)
DK (1) DK85084A (en)
ES (2) ES8503371A1 (en)
FI (1) FI840675L (en)
IL (1) IL71017A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515336C2 (en) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Process for the preparation and purification of â-interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
AU6032786A (en) * 1985-07-25 1987-01-29 University Of Minnesota Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
GB8615353D0 (en) * 1986-06-24 1986-07-30 Antibioticos Sa Interferon
DE3633323A1 (en) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int NEW MONOCLONAL ANTIBODIES AGAINST IFN-OMEGA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR CLEANING AND DETECTING IFN-OMEGA
SE468251B (en) 1989-06-20 1992-11-30 Bionative Ab CLEANING PROCESS FOR INTERFERON
JPH06502987A (en) * 1990-07-10 1994-04-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング O-glycosylated IFN-alpha
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
EP2073844A4 (en) 2006-12-06 2011-06-01 Medimmune Llc Methods of treating systemic lupus erythematosus
JP2010526107A (en) 2007-05-03 2010-07-29 メディミューン，エルエルシー Autoantibody markers for autoimmune diseases
AU2008324800B2 (en) 2007-11-05 2014-03-27 Astrazeneca Ab Methods of treating scleroderma
BRPI0908065A2 (en) 2008-02-08 2015-08-11 Medimmune Llc Methods for treating a patient who has an ifn type i or ifnalfa-mediated disease or disorder, to counteract a differentially regulated myna marker profile in a patient, to monitor or predict a progression of a patient's inflammatory disease and myositis disease, to monitor the progression of a patient's inflammatory or autoimmune disease and myositis disease and to treat a patient with myositis
ES2613055T3 (en) 2009-09-03 2017-05-22 Medimmune, Llc Type 1 interferon diagnosis
CN113508138B (en) 2019-02-15 2024-08-09 阿斯利康(瑞典)有限公司 Type I interferon-mediated disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (en) * 1979-04-20 1989-05-10 Technobiotic Ltd Process for the preparation and purification of human Le-shaped interferon protein.
WO1981002899A1 (en) * 1980-04-11 1981-10-15 D Secher Monoclonal antibody
FR2500754B1 (en) * 1981-02-27 1986-06-27 Hoffmann La Roche MONOCLONAL ANTIBODIES
JPS60500864A (en) * 1983-02-04 1985-06-06 ワドリ、テクナラジズ、インコーパレイティド Production and characterization of hybridoma antibodies specific for common determinants present between closely related but distinct proteins
GB8303165D0 (en) * 1983-02-04 1983-03-09 Secher D S Monoclonal antibody

Also Published As

Publication number Publication date
DK85084A (en) 1984-08-23
ES535509A0 (en) 1985-05-16
EP0119476A3 (en) 1987-04-08
ES529912A0 (en) 1985-02-16
ES8503371A1 (en) 1985-02-16
DK85084D0 (en) 1984-02-21
FI840675A7 (en) 1984-08-23
FI840675A0 (en) 1984-02-20
DE3306060A1 (en) 1984-08-23
ES8505409A1 (en) 1985-05-16
IL71017A0 (en) 1984-05-31
FI840675L (en) 1984-08-23
EP0119476A2 (en) 1984-09-26
JPS59224687A (en) 1984-12-17

Similar Documents

Publication Publication Date Title
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
EP0345461A3 (en) Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
EP0260610A3 (en) Monoclonal antibodies against human tumour necrotic factor (tnf), and their use
IL71621A0 (en) Use of alpha factor sequences in yeast expression systems
GB2109684B (en) Serum thymic factor for use in the treatment of immuno deficiency
AU3227684A (en) Detection of antibodies in human serum
IL71017A (en) Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha
AU6032786A (en) Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
PT85567A (en) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections
AU4688785A (en) Monoclonal antibodies to glycoconjugates and use in cancer detection and treatment
EP0240344A3 (en) Monoclonal antibodies and their use
EP0146866A3 (en) Phenylsulfonephthaleinyl-beta-d-galactosides, methods for their preparation and their use in the determination of beta-d-galactosidase
EP0114777A3 (en) Expression vehicles and their use in the preparation of a protein having human alpha-antitrypsin activity
GB8417338D0 (en) Human proteins antisera and test kits
GB2153364B (en) Lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
EP0131627A4 (en) Specific cea-family antigens, antibodies specific thereto and their methods of use.
EP0137258A3 (en) Zirconia-titania-silica tergels and their use as catalyst supports
IL84040A0 (en) Monoclonal antibodies against ifn-omega,their preparation and their use in the purification and detection of ifn-omega
ZA843060B (en) Use of alpha factor sequences in yeast expression systems
IL73941A0 (en) Ultrasonic detector cell and system
GB8403707D0 (en) Exhaust-gas recirculation system
GB2082769B (en) Improvements in ultrasonic diagnosis systems
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees